FindTrial
Sign In

Study of drug induced skin diseases

Epidemiological, Clinical, Dermoscopic and Histopathological Evaluation of Cutaneous Adverse Drug Reactions. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059485
Enrollment
133
Registered
2023-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 2: R21- Rash and other nonspecific skin eruption

Interventions

Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

NONE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both sexes and all ages Patients who are willing to take part in the study All patients attending dermatology OPD clinically diagnosed with Drug Rash

Exclusion criteria

Exclusion criteria: Patients who are not willing to take part in the study Patients who are not willing to give written consent

Design outcomes

Primary

MeasureTime frame
To find out information about Epidemiological Clinical Dermoscopic features of adverse cutaneous drug reactionsTimepoint: Baseline (only at the time of presentation)—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Shraddha Mahobia

Senior Consultant Head of Department Dermatology Venereology Leprology

swagatatambe@gmail.com9769381308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026